CLINICAL SIGNIFICANCE OF CD33 NON-SYNONYMOUS SINGLE NUCLEOTIDE POLYMORPHISMS (SNPs) IN PEDIATRIC PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH GEMTUZUMAB-OZOGAMICIN-CONTAINING CHEMOTHERAPY

PURPOSE: Purpose of this study was to evaluate clinical implications of CD33 SNPs in pediatric acute myeloid leukemia (AML) patients treated with gemtuzumab ozogamicin (GO) based therapy. EXPERIMENTAL DESIGN: We genotyped four CD33 SNPs: rs35112940 (G>A; Arg304Gly), rs12459419 (C>T; Ala14Val),...

詳細記述

保存先:
書誌詳細
主要な著者: Mortland, Leslie, Alonzo, Todd A, Walter, Roland B, Gerbing, Robert B, Mitra, AK, Pollard, Jessica A, Loken, Michael R, Hirsch, Betsy, Raimondi, Susana, Franklin, Janet, Pounds, Stanley, Cao, Xueyuan, Rubnitz, Jeffrey E, Ribeiro, Raul C, Gamis, Alan, Meshinchi, Soheil, Lamba, Jatinder K
フォーマット: Artigo
言語:Inglês
出版事項: 2013
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3602123/
https://ncbi.nlm.nih.gov/pubmed/23444229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-3115
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料